Correlation Between Liquidia Technologies and Ionis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Liquidia Technologies and Ionis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liquidia Technologies and Ionis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Liquidia Technologies and Ionis Pharmaceuticals, you can compare the effects of market volatilities on Liquidia Technologies and Ionis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liquidia Technologies with a short position of Ionis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liquidia Technologies and Ionis Pharmaceuticals.
Diversification Opportunities for Liquidia Technologies and Ionis Pharmaceuticals
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Liquidia and Ionis is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Liquidia Technologies and Ionis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ionis Pharmaceuticals and Liquidia Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liquidia Technologies are associated (or correlated) with Ionis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ionis Pharmaceuticals has no effect on the direction of Liquidia Technologies i.e., Liquidia Technologies and Ionis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Liquidia Technologies and Ionis Pharmaceuticals
Given the investment horizon of 90 days Liquidia Technologies is expected to generate 0.9 times more return on investment than Ionis Pharmaceuticals. However, Liquidia Technologies is 1.11 times less risky than Ionis Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Ionis Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 1,443 in Liquidia Technologies on January 13, 2025 and sell it today you would lose (96.00) from holding Liquidia Technologies or give up 6.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Liquidia Technologies vs. Ionis Pharmaceuticals
Performance |
| Timeline |
| Liquidia Technologies |
| Ionis Pharmaceuticals |
Liquidia Technologies and Ionis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Liquidia Technologies and Ionis Pharmaceuticals
The main advantage of trading using opposite Liquidia Technologies and Ionis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liquidia Technologies position performs unexpectedly, Ionis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ionis Pharmaceuticals will offset losses from the drop in Ionis Pharmaceuticals' long position.| Liquidia Technologies vs. Biomarin Pharmaceutical | Liquidia Technologies vs. Vaxcyte | Liquidia Technologies vs. Legend Biotech Corp | Liquidia Technologies vs. Bio Techne Corp |
| Ionis Pharmaceuticals vs. Arrowhead Pharmaceuticals | Ionis Pharmaceuticals vs. Biomarin Pharmaceutical | Ionis Pharmaceuticals vs. Incyte | Ionis Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |